No community center needs to build every part of a CAR-T program itself. Apheresis, product handling, transport and inpatient escalation can all be delivered by partners. The question is not what you can do alone, but which services you contract, and to whom.
Every community program is a mix of what it owns and what it buys. Deciding early which is which protects the capabilities that have to sit inside your practice and lets qualified providers carry the rest. The service areas below are the ones community centers most commonly place with an outside partner.
You do not have to build every capability yourself to run a CAR-T program. The work is deciding which pieces belong inside your practice, and which belong with a partner you trust.
Apheresis collection drives product quality and shapes the patient’s first experience of your program. It is also one of the most commonly contracted services, and several qualified providers can step into the need. Contracting collection lets a center move faster and concentrate its own effort on the capabilities that cannot be bought.
A community center treating patients in the outpatient setting needs a defined route to inpatient and ICU-level care before the first infusion. Published guidance calls for rapid access to emergency services and intensive care units capable of managing severe adverse reactions, and one community practice met this by partnering with a regional hospital. Agreements should name the admitting service, the escalation pathway and expected response times, and extend to ambulance, emergency department, ICU, neurology and cardiology.
Cell therapy products are patient-specific, arrive frozen and cannot be replaced, so receipt, storage and thaw call for pharmacy capability many community sites have not yet built. Distributors and other third-party providers can take on product handling, cold chain management, inventory management, regulatory compliance and contingency planning. Regulatory compliance, including chain of identity, chain of custody verification, is a shared responsibility so written compliance programs are needed.
Settle early how the product will be acquired and who carries the cost between purchase and payment. Under buy-and-bill, your center purchases, stores and administers the product and then submits a claim, so you hold both the inventory and the financial exposure. Specialty pharmacy and blended arrangements move some of that elsewhere. Distributors can also take on inventory management, ordering and regulatory compliance. Whichever channel you choose, agree it in writing before the first patient is scheduled.
Cell therapy moves on a schedule with little room for error, from collection to the manufacturing site and return. Distributors can carry cold chain management, logistics support, scheduling and coordination, and contingency planning, which removes substantial workload from the treatment center. This is subject to regulation so be sure your partner can assure compliance. Patient transport is a separate arrangement: an outpatient program also needs an agreed route to the hospital, including ambulance service, when a patient requires admission.
Coverage is the contracting conversation worth starting earliest. It is possible to secure prior authorization and single-case agreements with commercial payers before apheresis begins. It is worth confirming which of your existing contracts cover cell therapy at your site of care. Agree in advance who prepares single-case agreements and who handles appeals.
There is more than one way to structure a community CAR-T program. The right shape depends on what your organization already owns, how far away the nearest established center is, and how much of the program you intend to run yourself. Most centers end up combining these models rather than choosing one.
Your center partners with an established CAR-T program that covers what you do not build, with referral, handoff and follow-up responsibilities agreed in advance.
You contract directly with product developers and third-party providers. Site qualification with each manufacturer is what gives your center access to the product.
You draw on a parent or affiliated health system for inpatient beds, ICU escalation and accreditation infrastructure while treatment stays in the community setting.
A partner agreement is only as good as what it says about the difficult days. Before signing, settle who does what, how quickly they respond, and what happens if the arrangement ends. The items below are the terms most worth resolving in writing rather than by custom.
We’re here to help. Reach out today to connect with experts that can guide you.
